Angiotensin II Induces C-Reactive Protein Expression via AT1-ROS-MAPK-NF-κB Signal Pathway in Hepatocytes
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: C-reactive protein (CRP) participates in development of inflammatory diseases. Hepatocytes are a major contributor of circulating CRP. Although angiotensin II (Ang II) is known to evoke inflammatory response, it remains unknown whether Ang II induces CRP expression in hepatocytes. The present study observed effect of Ang II on CRP expression and the related signal pathway in hepatocytes. METHODS: mRNA and protein expressions in human hepatocytes were determined with RT-PCR and Western blot respectively. Reactive oxygen species (ROS) was measured using a fluorescence probe. CRP in liver and serum of rats was determined by immunohistochemistry and ELISA respectively. RESULTS: Ang II induced mRNA and protein expression of CRP in hepatocytes and increased CRP production in liver and CRP level in serum. Losartan reduced Ang II- induced CRP expression in hepatocytes. Losartan and thenoyltrifluoroacetone decreased Ang II-stimulated ROS production. N-acetylcysteine antagonized Ang II-induced CRP expression. Losartan and N-acetylcysteine inhibited Ang II-activated ERK1/2. Unlike ERK1/2, only losartan inhibited Ang II-activated JNK. Furthermore, pyrrolidine dithiocarbamate abolished Ang II-induced CRP expression. CONCLUSION: Ang II has ability to induce CRP expression in hepatocytes in vitro and in vivo through AT1 receptor followed by ROS, MAPK and NF-κB signal pathway.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“as angiotensin-II activity increases CRP and IL-6 release (Sano et al, 2001;Zhao et al, 2013).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Zhao et al, 2013
Citations
Cites
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor
Marrero, M. B., Schieffer, B., Paxton, W. G., Heerdt, L., Berk, B. C., Delafontaine, P., & Bernstein, K. E. (1995) · Nature · doi:10.1038/375247a0 · Cited by 745
Inflammation and angiotensin II
Suzuki, Y., Ruiz-Ortega, M., Lorenzo, O., Ruperez, M., Esteban, V., & Egido, J. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00271-6 · Cited by 694
Targeting C-reactive protein for the treatment of cardiovascular disease.
Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Ruth Gallimore, J., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., et al. (2006) · Nature · doi:10.1038/nature04672 · Cited by 672
Ushio-Fukai, M., Alexander, R. W., Akers, M., & Griendling, K. K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.24.15022 · Cited by 650
Reactive oxygen species as mediators of angiotensin II signaling
Griendling, K. K., & Ushio-Fukai, M. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00136-1 · Cited by 417
Proinflammatory actions of angiotensins
Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200105000-00005 · Cited by 412
Bataller, R., Sancho-bru, P., Ginès, P., Lora, J. M., Al-garawi, A., Solé, M., Colmenero, J., Nicolás, J. M., Jiménez, W., Weich, N., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00695-4 · Cited by 352
Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2
Paizis, G., Tikellis, C., Cooper, M. E., Schembri, J. M., Lew, R. A., Smith, A. I., Shaw, T., Warner, F. J., Zuilli, A., Burrell, L. M., et al. (2005) · Gut · doi:10.1136/gut.2004.062398 · Cited by 334
Cited by
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786
“However, these agents are also capable of reducing neuroinflammation (Benicky et al, 2011; Welty et al, 2015), as angiotensin-II activity increases CRP and IL-6 release (Sano et al, 2001; Zhao et al, 2013).”
BackgroundPosttraumatic stress disorder: A metabolic disorder in disguise?
Michopoulos, V., Vester, A., & Neigh, G. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.038 · Cited by 152
“, 2015), as angiotensin-II acts as a pro-inflammatory signal to induce the release of CRP (Peng et al., 2007; Zhao et al., 2013) and IL-6 (Sano et al.”
InfluentialCho, Y., Noh, K., Jue, S., Lee, S., & Kim, E. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12198 · Cited by 79
“The MAPK and NF-jB pathways are crucial for cell proliferation and differentiation in hepatocytes [45, 46].”
BackgroundLi, M., Liu, X. Z., He, Y., Zheng, Q., Wang, M., Wu, Y. C., Zhang, Y., & Wang, C. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.027 · Cited by 62
Bargut, T. C. L., Mandarim‐de‐Lacerda, C. A., & Águila, M. B. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.04.002 · Cited by 57
Involvement of circulating inflammatory factors in prognosis and risk of cardiovascular disease
Haybar, H., Shokouhian, M., Bagheri, M., Davari, N., & Saki, N. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.05.010 · Cited by 60
Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell Damage
Takeuchi, M., Sakai, A., Takata, T., Takino, J.-I., Koriyama, Y., Kikuchi, C., Furukawa, A., Nagamine, K., Hori, T., & Matsunaga, T. (2021) · Biomolecules · doi:10.3390/biom11030387 · Cited by 57
“ROS were also shown to increase the expression levels of CRP in hepatocytes [80], suggesting the initiation of inflammatory responses by GA-induced ROS, which is characteristic of NASH.”
BackgroundNejat, R., & Sadr, A. S. (2020) · In Silico Pharmacology · doi:10.1007/s40203-020-00058-7 · Cited by 48
Oliveira, S. H. P., Brito, V. G. B., Frasnelli, S. C. T., Ribeiro, B. D. S., Ferreira, M. N., Queiroz, D. P., Beltan, C., Lara, V. S., & Santos, C. F. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00708 · Cited by 37
“Elevated levels of CXCL2 leads to increased recruitment of neutrophils to periodontal ligaments in diabetic mice with induced PD (Greer et al., 2016; Zheng et al., 2018).”
BackgroundYamamoto, M., Kobayashi, T., Kuroda, S., Hamaoka, M., Okimoto, S., Honmyo, N., Yamaguchi, M., & Ohdan, H. (2019) · Annals of Gastroenterological Surgery · doi:10.1002/ags3.12286 · Cited by 35
Yang, S., Sun, D., Wang, L., Wang, X., Shi, M., Jiang, X., & Gao, X. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.10.021 · Cited by 37
Sakai, A., Takata, T., & Takeuchi, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144861 · Cited by 37
“Furthermore, ROS were found to up-regulate the expression of CRP in hepatocytes [41], suggesting that GA-induced ROS initiate an inflammatory response that is a feature of NASH.”
BackgroundAfroze, S. H., Munshi, M. K., Martínez, A. K., Uddin, M. N., Gergely, M., Szynkarski, C. K., Guerrier, M., Nizamutdinov, D., Dostal, D. E., & Glaser, S. S. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00116.2014 · Cited by 29
“Hepatocytes are also positive for the expression of RAS components as expected (76).”
BackgroundDong, Y., Zhu, H., Chen, L., Huang, Y., Christen, W. G., Cook, N. R., Copeland, T., Mora, S., Buring, J. E., Lee, I.-M. M., et al. (2022) · Nutrients · doi:10.3390/nu14245307 · Cited by 37
“Another study showed that NF-κB inhibitor significantly inhibited CRP protein expression [38].”
BackgroundZhao, J., Yang, H., Chen, B., & Zhang, R. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.023 · Cited by 26
Self-citationChen, J., Gong, F., Chen, M., Li, C., Hong, P., Sun, S., Zhou, C., & Qian, Z. (2019) · Marine Drugs · doi:10.3390/md17070431 · Cited by 26
“On one hand, the augmentation of ROS in oxidative stress, with the ability to stimulate the expression of pro-inflammatory factors [37], may further lead to endothelial dysfunction, lipid oxidation, and inflammatory responses [38].”
BackgroundSakai, A., Takeda, K., & Takeuchi, M. (2023) · Antioxidants · doi:10.3390/antiox12030748 · Cited by 24
“A previous study demonstrated that ROS up-regulated the expression of C-reactive protein (CRP) in the human normal liver cell line, L-02 [94].”
BackgroundPerspectives of (/memorandum for) systems thinking on COVID‐19 pandemic and pathology
Tretter, F., Peters, E. M. J., Sturmberg, J. P., Bennett, J. M., Voit, E. O., Dietrich, J. W., Smith, G., Weckwerth, W., Grossman, Z., Wolkenhauer, O., et al. (2022) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13772 · Cited by 19
Jun, J. H., Choi, J. H., Bae, S. H., Oh, S., & Kim, G. J. (2016) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2016.0032 · Cited by 13
“It is principally synthesized and regulated in response to interleukin-6 (IL-6) or interleukin-1β (IL-1β) in hepatocytes.(8) It has been reported that CRP expression levels are associated with liver diseases such as hepatitis, nonalcoholic fatty liver disease (NAFLD), and fibrosis.”
BackgroundZhao, J., Liu, J., Pang, X., Zhang, X., Wang, S., & Wu, D. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1279-6 · Cited by 14
“Earlier studies confirm that ROS mediate MAPK signaling (Wei et al. 2008), and Ang II activates ERK1/2 by stimulating production of ROS in hepatocytes (Zhao et al. 2013).”
BackgroundMethodInfluentialSelf-citationRole of Angiotensin II in Non-Alcoholic Steatosis Development
Alvarado-Ojeda, Z. A., Trejo-Moreno, C., Ferat-Osorio, E. A., Méndez-Martínez, M., Fragoso, G., & Rosas-Salgado, G. (2024) · Archives of Medical Research · doi:10.1016/j.arcmed.2024.102986 · Cited by 14
Ye, L., Qian, Y., Li, Q., Fang, S., Yang, Z., Tan, Y. L., & Gu, W. (2018) · Sleep And Breathing · doi:10.1007/s11325-017-1606-2 · Cited by 12
Preparation and antagonistic effect of ACE inhibitory peptide from cashew
Shu, Y., Cao, X., & Chen, J. (2019) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.9967 · Cited by 12
Taşkın, E., Güven, C., Şahin, L., & Dursun, N. (2016) · Medical Science Monitor · doi:10.12659/msm.895845 · Cited by 11
“Interference of Ang-II in Adriamycin hepatotoxicity is associated with stimulating ROS production in hepatocytes, mainly via AT-1 and mitochondria-derived pathway because losartan can inhibit Ang-II-stimulated ROS generation [11].”
BackgroundInfluentialZhao, J., Liu, J., Pang, X., Zhang, X., Wang, S., & Wu, D. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.12.026 · Cited by 11
Self-citationWang, C., Zhang, C., Zhou, F., Gao, L., Wang, Y., Wang, C., & Zhang, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7971 · Cited by 7
“In addition, Ang II through its Ang II receptor type 1 (AT1R) promotes ROS generation in hepatocytes (9).”
Lee, S., Lee, H., Kim, S., Lee, J., Ha, J., Choi, Y., Oh, H., Kim, Y., Lee, Y., Choi, K., et al. (2020) · BioMed Research International · doi:10.1155/2020/7929610 · Cited by 9
“of PCNA has been used to assess proliferative activity in normal, regenerative, and tumoral livers in humans and rodents [22].”
BackgroundUeda, J., Mamada, Y., Taniai, N., Yoshioka, M., Hirakata, A., Kawano, Y., Shimizu, T. M., Kanda, T., Takata, H., Kondo, R., et al. (2020) · World Journal of Surgery · doi:10.1007/s00268-020-05570-7 · Cited by 3
Zhang, H., Zhu, J., He, H., Li, B., Wang, H., Chen, L., & Ni, Q. (2025) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-06443-2 · Cited by 1
“In addition, AT1R participates in regulating vasoconstriction, resulting in tissue ischemia–reperfusion, which leads to the release of oxygen free radicals [16].”
Gaus, S., Afif, Y., Husain, A. A. A., Tanra, A. H., Ratnawati, R., & Rum, M. (2023) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2023.10853 · Cited by 4
Mojica, Á. A. D., Pedreáñez, A. B., Valero-Cedeño, N., Vargas, R., & Mosquera-Sulbarán, J. (2026) · Pediatric Nephrology · doi:10.1007/s00467-026-07533-x
Metadata
- Authors
- Zhao, J., Liu, J., Pang, X., Wang, S., Wu, D., Zhang, X., & Feng, L.
- Affiliations
- Xi'an Jiaotong University (CN)
- Venue
- Cellular Physiology and Biochemistry
- Publisher
- S. Karger AG
- Published
- 2013
- Volume
- 32
- Issue
- 3
- Pages
- 569-580
- ISSN
- 1015-8987 (ISSN-L)
- 1421-9778
- OpenAlex
- W2054099082
- Cited by
- 31
- References
- 37
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 6 · 2018: 2 · 2017: 2 · 2016: 5 · 2015: 3 · 2014: 1
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/3.0/ (vor)
- creativecommons.org/licenses/by-nc/3.0/ (tdm)
- Locations
- Cellular Physiology and Biochemistry (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Ministry of Education of the People's Republic of China
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- angiotensin II, C-reactive protein, hepatocytes, angiotensin II type 1 receptor, reactive oxygen species, MAPK signaling, NF-κB, ERK1/2, JNK, losartan, N-acetylcysteine, thenoyltrifluoroacetone, pyrrolidine dithiocarbamate, inflammation, liver
- MeSH terms
- Acetylcysteine, Angiotensin II, Animals, C-Reactive Protein, Cell Line, Humans, Male, Recombinant Proteins, RNA, Messenger, Thenoyltrifluoroacetone, Signal Transduction, NF-kappa B, Rats, Sprague-Dawley, Reactive Oxygen Species, Losartan, Mitogen-Activated Protein Kinase 1, Hepatocytes, Receptor, Angiotensin, Type 1, JNK Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.